Drawing for BERKO

USPTO serial 79114705

BERKO

Reviewed by CopyMark Law Group

Reg. 4405103Status 706Registered
Filing date
Status date
Registration date
Sep 24, 2013
Examiner
THOMAS, JANICE
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with BERKO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark David Torche

Mark David Torche Patwrite Law408 W, Main St.Marshalltown, IA 50158UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003[ Soaps, namely, soaps used for the treatment of hair loss, bath soaps, skin soaps, liquid soaps ]SECTION 71 - CANCELLED—
005[ Pharmaceuticals for human health in the treatment of anemia and assisting energy metabolism; systemic anti-infectives, namely, antibacterial and antifungal pharmaceuticals; musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; cardiovascular pharmaceuticals, namely, diuretics, lipid lowering agents, beta blocking agents, calcium antagonists and other cardiovascular products; pharmaceuticals for the prevention and treatment of disorders of the nervous system, namely, analgesics, psychoanaleptics, psycoleptics, anti-epileptics, central nervous system drugs, anaesthetics, anti-Parkinson preparations; pharmaceuticals for the treatment of respiratory diseases and asthma; dermatological pharmaceutical products; pharmaceuticals for the treatment of hormonal disorders and the prevention of osteoporosis; anti-diabetic pharmaceuticals; pharmaceuticals for the treatment of bone diseases and joint diseases; pharmaceuticals for the treatment of viral and infectious diseases; pharmaceuticals for use as antineoplastic agents; pharmaceuticals for the treatment of immune system related diseases and disorders; pharmaceuticals for the treatment of kidney diseases; pharmaceuticals for ophthalmological use; chemical preparations for medical purposes, namely, a vitamin and mineral supplement to support the growth of children, vitamins and dietary supplements to support arousing the appetite ]SECTION 71 - CANCELLED—
029Supplementary food products, not for medical purposes, mostly consisting of proteins [ and also containing carbohydrates, proteins and pollen, namely, pollen prepared as food stuffs, protein milk, and textured vegetable protein for use as a meat extender ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 21, 2024INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Oct 17, 2024XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Oct 15, 2024XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 2, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 1, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 1, 202471AGREGISTERED-SEC.71 ACCEPTED—
Jan 31, 2024ES71TEAS SECTION 71 RECEIVED—
Jan 29, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 29, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 29, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 24, 2022REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Feb 10, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Mar 13, 2021INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jan 22, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 13, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 13, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Jan 5, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 5, 2020NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 5, 202071.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
May 1, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 24, 2020ES71TEAS SECTION 71 RECEIVED—
Mar 24, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 24, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 24, 2020EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Mar 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 24, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 15, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 3, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 8, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 16, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 16, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 31, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 31, 2013FIMPFINAL DISPOSITION PROCESSED—
Dec 24, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 24, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 5, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 21, 2013GPNXNOTIFICATION PROCESSED BY IB—
Jul 9, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 19, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 19, 2013NPUBNOTICE OF PUBLICATION—
Jun 4, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 4, 2013ALIEASSIGNED TO LIE—
Jun 3, 2013CNEAEXAMINERS AMENDMENT MAILED—
Jun 3, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 3, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Jun 3, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
May 24, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 24, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 24, 2013ALIEASSIGNED TO LIE—
May 22, 2013NREVNOTICE OF REVIVAL - MAILED—
May 22, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2013PETGPETITION TO REVIVE-GRANTED—
May 22, 2013PROATEAS PETITION TO REVIVE RECEIVED—
Mar 22, 2013MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 22, 2013ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 17, 2012RFNTREFUSAL PROCESSED BY IB—
Jul 28, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 27, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 27, 2012RFRRREFUSAL PROCESSED BY MPU—
Jul 27, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 26, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2012DOCKASSIGNED TO EXAMINER—
Jul 24, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 20, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance